TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Pfizer Anti-Infectives AB
Closing information (x1000 NOK)
Closing information | 2022/11 | 2021/11 | 2020/11 |
Turnover |
1,280,955
|
330,539
|
1,592,593 |
Financial expenses |
447
|
1,267
|
2 |
Earnings before taxes |
392,998
|
-567,272
|
1,273,440 |
EBITDA |
449,477
|
-506,808 | |
Total assets |
1,496,197
|
1,142,811
|
1,776,022 |
Current assets |
106,356
|
217,702
|
1,053 |
Current liabilities |
592,261
|
517,453
|
655,073 |
Equity capital |
903,936
|
625,358
|
1,120,949 |
- share capital |
47
|
50
|
52 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2022/11 | 2021/11 | 2020/11 |
Solvency |
60.4%
|
54.7%
|
63.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
30.7%
|
-171.6%
|
80.0% |
Return on assets (ROA) |
26.3%
|
-49.5%
|
71.7% |
Current ratio |
18.0%
|
42.1%
|
0.2% |
Return on equity (ROE) |
43.5%
|
-90.7%
|
113.6% |
Change turnover |
968,092
|
-1,197,883
|
1,592,593 |
Change turnover % |
309%
|
-78% | |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/11 | 2021/11 | 2020/11 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.